908 Devices (NASDAQ:MASS) SVP Kevin Mccallion Sells 2,693 Shares

908 Devices Inc. (NASDAQ:MASS) SVP Kevin Mccallion sold 2,693 shares of 908 Devices stock in a transaction on Friday, April 10th. The stock was sold at an average price of $7.01, for a total transaction of $18,877.93. Following the transaction, the senior vice president directly owned 44,925 shares of the company’s stock, valued at $314,924.25. The trade was a 5.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Trading Up 1.7%

Shares of MASS opened at $7.32 on Wednesday. The firm has a market capitalization of $273.62 million, a P/E ratio of 13.31 and a beta of 0.54. 908 Devices Inc. has a 12-month low of $4.14 and a 12-month high of $9.34. The firm has a fifty day moving average price of $6.51 and a 200-day moving average price of $6.65.

908 Devices (NASDAQ:MASS) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. The firm had revenue of $17.38 million during the quarter, compared to analyst estimates of $16.19 million. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. Analysts predict that 908 Devices Inc. will post -1.99 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MASS. Wall Street Zen raised shares of 908 Devices from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Weiss Ratings raised shares of 908 Devices from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $12.00.

Institutional Trading of 908 Devices

Several institutional investors and hedge funds have recently made changes to their positions in MASS. First Light Asset Management LLC raised its holdings in shares of 908 Devices by 92.6% in the fourth quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company’s stock valued at $25,390,000 after acquiring an additional 2,325,690 shares in the last quarter. Needham Investment Management LLC raised its holdings in shares of 908 Devices by 246.8% in the fourth quarter. Needham Investment Management LLC now owns 770,000 shares of the company’s stock valued at $4,042,000 after acquiring an additional 548,000 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of 908 Devices by 359.4% in the second quarter. Marshall Wace LLP now owns 648,796 shares of the company’s stock valued at $4,626,000 after acquiring an additional 507,562 shares in the last quarter. First Eagle Investment Management LLC raised its holdings in shares of 908 Devices by 125.9% in the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company’s stock valued at $5,291,000 after acquiring an additional 336,584 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of 908 Devices by 221.7% in the second quarter. Bank of America Corp DE now owns 363,217 shares of the company’s stock valued at $2,590,000 after acquiring an additional 250,311 shares in the last quarter. 88.06% of the stock is currently owned by institutional investors.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.